Florent Bordet

Chief Scientific Officer at Aenova

Greater Strasbourg Metropolitan Area

About

Global pharmaceutical leader with extensive hands-on experience in Site Management, Technical Operations and Drug Development. Proven record of site turnaround in safety, quality, delivery and financial performance. Track record of success in project management in drug product development from clinical phases through to commercial launch, in technology transfer programs across multiple plants as well as in global manufacturing process harmonization, troubleshooting and innovation programs across 10+ facilities worldwide. Experienced in M&A Due Diligence executions as well as in Divestiture processes. Highly motivated professional with strong leadership and communication skills. Result oriented technical leader skilled at building and developing teams and thriving in international environments and fast-paced organizations.

Experience

  • Aenova Group ()
    • Chief Scientific Officer
      Jun 2023 - Present · 3 yrs 2 mos

      In charge of driving Innovation at Aenova, growing Pharmaceutical Development as well as Manufacturing, Science and Technology programs across multiple Technology Platforms

    • SVP/General Manager, Business Unit Semi-Solids and Liquids
      Nov 2019 - May 2023 · 3 yrs 7 mos

      Head of Aenova's SEL Business Unit including multiple sites offering semi-solid, liquid, sterile technologies for human health and animal health products, distributed globally, as well as providing oversight for Group Continuous Improvement and Group Engineering.

  • Vice President, Operations at FAMAR
    Feb 2018 - Nov 2019 · 1 yr 10 mos

    Head of Group Operations including operational performance of the sites across technologies (Sterile, Solid Dose, Liquids) and including Global EHS, Engineering, Continuous Improvement and Technical Services.

  • Independent Consultant at Independent Consultant
    Oct 2016 - Jan 2018 · 1 yr 4 mos

    Technical Operations and Product Development consulting to pharmaceutical and dietary supplement companies.

  • Catalent Pharma Solutions (8 yrs 1 mo)
    • Business Transformation Leader
      Feb 2016 - Sep 2016 · 8 mos

      Leading strategic programs across multiple Catalent sites, third parties and transformational initiatives including M&A related activities and Business Continuity and Technology Transfer Plans for key commercial products and strategic product development programs.

    • Site General Manager
      Oct 2010 - Jan 2016 · 5 yrs 4 mos

      Operations and P&L responsibility for a FDA approved Softgel Manufacturing site (315 employees) based in North Eastern France.

    • Technical Services Director, Oral Technologies
      Apr 2009 - Oct 2010 · 1 yr 7 mos

      In charge of technical operations programs for the 10 softgel sites of Catalent at a global level: harmonization/best practice sharing, facility revamping projects, global capacity and product transfer strategy programs.

  • Cardinal Health (7 yrs 3 mos)
    • Operations Director
      Jul 2002 - Aug 2008 · 6 yrs 2 mos

      In charge of industrial operations for Cardinal Health France Softgel Manufacturing Site - Including interim site management role in 2007 and dual role of Operations Director role at Cardinal Health Swindon (UK) Softgel Manufacturing Site in 2006

    • Production Manager
      Jun 2001 - Jul 2002 · 1 yr 2 mos